|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
3
|
Zenith Epigenetics
|
Apr 14, 2022 01:12PM
|
|
Club or Business
|
9
|
Resverlogix Corp.
|
Apr 17, 2022 11:59AM
|
|
Re: Exempt Distribution - 2022-04-14
|
6
|
Resverlogix Corp.
|
Apr 19, 2022 12:08PM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
12
|
Resverlogix Corp.
|
Apr 20, 2022 11:51AM
|
|
HDL and apabetalone
|
11
|
Resverlogix Corp.
|
Apr 23, 2022 11:42AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 26, 2022 01:27PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
7
|
Resverlogix Corp.
|
Apr 27, 2022 06:39PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 27, 2022 06:45PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 28, 2022 11:11AM
|
|
Monday Morning Quarterback
|
11
|
Resverlogix Corp.
|
May 03, 2022 11:32AM
|
|
Re: PFE "is only the start of the spending spree that the company has planned"maybe,just maybe
|
7
|
Resverlogix Corp.
|
May 11, 2022 02:19PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
4
|
Zenith Epigenetics
|
May 12, 2022 01:13PM
|
|
AGM June 21
|
5
|
Resverlogix Corp.
|
May 13, 2022 01:29PM
|
|
Re: AGM June 21
|
3
|
Resverlogix Corp.
|
May 13, 2022 06:20PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 15, 2022 07:06PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 16, 2022 07:16PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
4
|
Zenith Epigenetics
|
May 18, 2022 10:38AM
|
|
Re: great,good,bad,ugly or so so??
|
6
|
Resverlogix Corp.
|
May 18, 2022 11:11AM
|
|
Re: great,good,bad,ugly or so so??
|
2
|
Resverlogix Corp.
|
May 18, 2022 01:28PM
|
|
Re: great,good,bad,ugly or so so??
|
6
|
Resverlogix Corp.
|
May 18, 2022 06:15PM
|
